An open label trial of telbivudine (LdT) in adults with chronic hepatitis B previously treated in Idenix-sponsored telbivudine studies. [Studio in aperto su Telbivudina (LdT)in soggetti adulti affetti da epatite B cronica trattati in precedenza nel corso di studi sponsorizzati da Idenix]
Phase of Trial: Phase III
Latest Information Update: 23 Apr 2015
At a glance
- Drugs Telbivudine (Primary)
- Indications Hepatitis B
- Focus Adverse reactions; Therapeutic Use
- Sponsors Novartis
- 10 Jun 2017 Biomarkers information updated
- 22 Jul 2011 Actual initiation date (Mar 2005) added as reported by ClinicalTrials.gov.
- 22 Jul 2011 Additional trial locations identified as reported by ClinicalTrials.gov.